Camtek (NASDAQ:CAMT) PT Set at $80.00 by Cantor Fitzgerald

Camtek (NASDAQ:CAMTGet Free Report) received a $80.00 price target from stock analysts at Cantor Fitzgerald in a research report issued on Tuesday, Marketbeat.com reports. The brokerage currently has a “neutral” rating on the semiconductor company’s stock. Cantor Fitzgerald’s price objective would indicate a potential downside of 2.55% from the stock’s current price.

A number of other research analysts have also recently commented on CAMT. B. Riley increased their target price on Camtek from $85.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, May 14th. Northland Securities set a $105.00 target price on Camtek in a research note on Wednesday, May 14th. Jefferies Financial Group reduced their target price on Camtek from $120.00 to $85.00 and set a “buy” rating on the stock in a research note on Friday, March 28th. Barclays reduced their target price on Camtek from $120.00 to $85.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 22nd. Finally, Bank of America reduced their price objective on Camtek from $105.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, April 16th. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.56.

View Our Latest Stock Report on Camtek

Camtek Price Performance

Shares of NASDAQ CAMT opened at $82.09 on Tuesday. The firm has a market capitalization of $3.74 billion, a P/E ratio of 31.45, a P/E/G ratio of 2.21 and a beta of 1.29. The company has a quick ratio of 4.27, a current ratio of 5.28 and a debt-to-equity ratio of 0.34. The stock’s 50-day simple moving average is $68.80 and its two-hundred day simple moving average is $74.43. Camtek has a twelve month low of $47.41 and a twelve month high of $140.50.

Camtek (NASDAQ:CAMTGet Free Report) last released its earnings results on Tuesday, May 13th. The semiconductor company reported $0.79 EPS for the quarter, beating analysts’ consensus estimates of $0.77 by $0.02. The business had revenue of $118.64 million for the quarter, compared to analysts’ expectations of $119.00 million. Camtek had a return on equity of 24.57% and a net margin of 28.40%. The firm’s revenue was up 22.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.63 earnings per share. As a group, equities analysts anticipate that Camtek will post 2.93 EPS for the current fiscal year.

Institutional Investors Weigh In On Camtek

Several institutional investors have recently bought and sold shares of the stock. Clal Insurance Enterprises Holdings Ltd boosted its holdings in Camtek by 27.8% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,134,671 shares of the semiconductor company’s stock valued at $123,622,000 after acquiring an additional 464,671 shares during the period. Menora Mivtachim Holdings LTD. grew its stake in shares of Camtek by 81.8% in the fourth quarter. Menora Mivtachim Holdings LTD. now owns 1,566,433 shares of the semiconductor company’s stock worth $126,521,000 after purchasing an additional 705,000 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. grew its stake in shares of Camtek by 27.6% in the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,448,441 shares of the semiconductor company’s stock worth $84,922,000 after purchasing an additional 312,988 shares during the last quarter. Wasatch Advisors LP grew its stake in shares of Camtek by 311.8% in the fourth quarter. Wasatch Advisors LP now owns 1,192,784 shares of the semiconductor company’s stock worth $96,341,000 after purchasing an additional 903,126 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Camtek by 110.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,015,307 shares of the semiconductor company’s stock worth $59,527,000 after purchasing an additional 532,944 shares during the last quarter. 41.93% of the stock is currently owned by hedge funds and other institutional investors.

Camtek Company Profile

(Get Free Report)

Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for semiconductor industry. The company provides Eagle-i, a system that delivers 2D inspection and metrology capabilities; Eagle-AP, which addresses the advanced packaging market using software and hardware technologies that deliver superior 2D and 3D inspection and metrology capabilities on the same platform; and Golden Eagle, a panel inspection and metrology system to address the challenges fanout wafer level packaging applications.

Featured Articles

Analyst Recommendations for Camtek (NASDAQ:CAMT)

Receive News & Ratings for Camtek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Camtek and related companies with MarketBeat.com's FREE daily email newsletter.